BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Naini BV, Souza RF, Odze RD. Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists. Am J Surg Pathol. 2016;40:e45-e66. [PMID: 26813745 DOI: 10.1097/pas.0000000000000598] [Cited by in Crossref: 54] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Martinez P, Mallo D, Paulson TG, Li X, Sanchez CA, Reid BJ, Graham TA, Kuhner MK, Maley CC. Evolution of Barrett's esophagus through space and time at single-crypt and whole-biopsy levels. Nat Commun 2018;9:794. [PMID: 29476056 DOI: 10.1038/s41467-017-02621-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
2 Gupta N, Yelamanchi R, Agrawal H, Agarwal N. Role of optical coherence tomography in Barrett’s esophagus. Artif Intell Gastrointest Endosc 2021; 2(4): 149-156 [DOI: 10.37126/aige.v2.i4.149] [Reference Citation Analysis]
3 Saller J, Al Diffalha S, Neill K, Bhaskar RA, Oliveri C, Boulware D, Levine H, Kalvaria I, Corbett FS, Khazanchi A, Klapman J, Coppola D. CDX-2 Expression in Esophageal Biopsies Without Goblet Cell Intestinal Metaplasia May Be Predictive of Barrett's Esophagus. Dig Dis Sci 2020;65:1992-8. [PMID: 31691172 DOI: 10.1007/s10620-019-05914-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 D'Souza SM, Houston K, Keenan L, Yoo BS, Parekh PJ, Johnson DA. Role of microbial dysbiosis in the pathogenesis of esophageal mucosal disease: A paradigm shift from acid to bacteria? World J Gastroenterol 2021; 27(18): 2054-2072 [PMID: 34025064 DOI: 10.3748/wjg.v27.i18.2054] [Reference Citation Analysis]
5 Hoang AT, Vizio B, Chiusa L, Cimino A, Solerio D, Do NH, Pileci S, Camandona M, Bellone G. Impact of Tissue Enolase 1 Protein Overexpression in Esophageal Cancer Progression. Int J Med Sci 2021;18:1406-14. [PMID: 33628097 DOI: 10.7150/ijms.52688] [Reference Citation Analysis]
6 Singer ME, Smith MS. Wide Area Transepithelial Sampling with Computer-Assisted Analysis (WATS3D) Is Cost-Effective in Barrett's Esophagus Screening. Dig Dis Sci 2021;66:1572-9. [PMID: 32578042 DOI: 10.1007/s10620-020-06412-1] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Dzinic SH, Mahdi Z, Bernardo MM, Vranic S, Beydoun H, Nahra N, Alijagic A, Harajli D, Pang A, Saliganan DM, Rahman AM, Skenderi F, Hasanbegovic B, Dyson G, Beydoun R, Sheng S. Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma. PLoS One 2019;14:e0215089. [PMID: 31002675 DOI: 10.1371/journal.pone.0215089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Neyaz A, Odze RD, Rickelt S, Nieman LT, Bledsoe JR, Mahadevan KK, Arora K, Jeck WR, Taylor MS, Gala M, Patil DT, Yilmaz OH, Rivera MN, Ting DT, Deshpande V. LGR5 in Barrett's Esophagus and its Utility in Predicting Patients at Increased Risk of Advanced Neoplasia. Clin Transl Gastroenterol 2020;12:e00272. [PMID: 33464729 DOI: 10.14309/ctg.0000000000000272] [Reference Citation Analysis]
9 Castela J, Serrano M, Ferro SM, Pereira DV, Chaves P, Pereira AD. Buried Barrett's Esophagus with High-Grade Dysplasia after Radiofrequency Ablation.Clin Endosc. 2019;52:269-272. [PMID: 30300980 DOI: 10.5946/ce.2018.124] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Schmidt M, Hackett RJ, Baker AM, McDonald SAC, Quante M, Graham TA. Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34728819 DOI: 10.1038/s41575-021-00531-4] [Reference Citation Analysis]
11 Mor A, Kobus K, Leszczyńska U, Reszeć J. Differentiating dysplasia markers in Barrette sophagus and adenocarcinoma. Postepy Hig Med Dosw 2019;73:608-25. [DOI: 10.5604/01.3001.0013.5643] [Reference Citation Analysis]
12 Snyder P, Dunbar K, Cipher DJ, Souza RF, Spechler SJ, Konda VJA. Aberrant p53 Immunostaining in Barrett's Esophagus Predicts Neoplastic Progression: Systematic Review and Meta-Analyses. Dig Dis Sci 2019;64:1089-97. [PMID: 30911864 DOI: 10.1007/s10620-019-05586-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
13 Odze RD, Goldblum J, Kaul V. Role of Wide-Area Transepithelial Sampling With 3D Computer-Assisted Analysis in the Diagnosis and Management of Barrett's Esophagus. Clin Transl Gastroenterol 2021;12:e00422. [PMID: 34874019 DOI: 10.14309/ctg.0000000000000422] [Reference Citation Analysis]
14 Adanir H, Baş B, Pakoz B, Günay S, Camyar H, Ustaoglu M. Endoscopic Findings of Gastro-Esophageal Reflux Disease in Elderly and Younger Age Groups. Front Med (Lausanne) 2021;8:606205. [PMID: 34957130 DOI: 10.3389/fmed.2021.606205] [Reference Citation Analysis]
15 Kaul V, Gross S, Corbett FS, Malik Z, Smith MS, Tofani C, Infantolino A. Clinical utility of wide-area transepithelial sampling with three-dimensional computer-assisted analysis (WATS3D) in identifying Barrett's esophagus and associated neoplasia. Dis Esophagus 2020;33:doaa069. [PMID: 32607543 DOI: 10.1093/dote/doaa069] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Odze R. Histology of Barrett's Metaplasia: Do Goblet Cells Matter? Dig Dis Sci 2018;63:2042-51. [PMID: 29998421 DOI: 10.1007/s10620-018-5151-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chambers JK, Saito T, Fukushima K, Kakuta S, Nakayama J, Ohno K, Tsujimoto H, Nakayama H, Uchida K. Adenocarcinoma of Barrett's esophagus in a dog. J Toxicol Pathol 2017;30:239-43. [PMID: 28798532 DOI: 10.1293/tox.2017-0009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
18 Okumura K, Hojo Y, Tomita T, Kumamoto T, Nakamura T, Kurahashi Y, Ishida Y, Hirota S, Miwa H, Shinohara H. Accuracy of Preoperative Endoscopy in Determining Tumor Location Required for Surgical Planning for Esophagogastric Junction Cancer. J Clin Med 2021;10:3371. [PMID: 34362152 DOI: 10.3390/jcm10153371] [Reference Citation Analysis]
19 Huhta H, Melkko J, Kuopio T, Karttunen TJ, Helminen O. Risk of progression in Barrett's esophagus based on diagnoses of general and gastrointestinal pathologists. A retrospective case-control study from Northern and Central Finland. Scand J Gastroenterol 2022;:1-6. [PMID: 35450519 DOI: 10.1080/00365521.2022.2063033] [Reference Citation Analysis]
20 Henry G, Malewska A, Mauck R, Gahan J, Hutchinson R, Torrealba J, Francis F, Roehrborn C, Strand D. Molecular pathogenesis of human prostate basal cell hyperplasia. Prostate 2017;77:1344-55. [PMID: 28795417 DOI: 10.1002/pros.23394] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
21 McDaniel M, Conran RM. Educational Case: Barrett Esophagus. Acad Pathol 2019;6:2374289519848089. [PMID: 31192298 DOI: 10.1177/2374289519848089] [Reference Citation Analysis]
22 Shiflett BS, Ekanayake LS, Rodriguez AL, Ikramuddin I, Myers C. Esophageal Adenocarcinoma in the Proximal Esophageal Segment: A Unique Presentation in a Male With Alcohol Abuse. Cureus 2020;12:e8863. [PMID: 32754402 DOI: 10.7759/cureus.8863] [Reference Citation Analysis]
23 Zheng J, Gao P. Toward Normalization of the Tumor Microenvironment for Cancer Therapy. Integr Cancer Ther 2019;18:1534735419862352. [PMID: 31282197 DOI: 10.1177/1534735419862352] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
24 Spechler SJ, Merchant JL, Wang TC, Chandrasoma P, Fox JG, Genta RM, Goldenring JR, Hayakawa Y, Kuipers EJ, Lund PK, McKeon F, Mills JC, Odze RD, Peek RM Jr, Pham T, Que J, Rustgi AK, Shaheen NJ, Shivdasani RA, Souza RF, Storz P, Todisco A, Wang DH, Wright NA. A Summary of the 2016 James W. Freston Conference of the American Gastroenterological Association: Intestinal Metaplasia in the Esophagus and Stomach: Origins, Differences, Similarities and Significance. Gastroenterology 2017;153:e6-e13. [PMID: 28583825 DOI: 10.1053/j.gastro.2017.05.050] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
25 Martin DR, Braxton DR, Farris AB. Dysplasia discrimination in intestinal-type neoplasia of the esophagus and colon via digital image analysis. Virchows Arch 2016;469:405-15. [PMID: 27492044 DOI: 10.1007/s00428-016-1999-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
26 Maslyonkina KS, Konyukova AK, Alexeeva DY, Sinelnikov MY, Mikhaleva LM. Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression. Cancer Med 2021. [PMID: 34870375 DOI: 10.1002/cam4.4447] [Reference Citation Analysis]
27 Konda VJA, Souza RF. Biomarkers of Barrett's Esophagus: From the Laboratory to Clinical Practice. Dig Dis Sci. 2018;63:2070-2080. [PMID: 29713984 DOI: 10.1007/s10620-018-5088-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
28 Zarrilli G, Galuppini F, Angerilli V, Munari G, Sabbadin M, Lazzarin V, Nicolè L, Biancotti R, Fassan M. miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma. Int J Mol Sci 2021;22:3640. [PMID: 33807389 DOI: 10.3390/ijms22073640] [Reference Citation Analysis]
29 Choi WT, Lauwers GY, Montgomery EA. Utility of ancillary studies in the diagnosis and risk assessment of Barrett's esophagus and dysplasia. Mod Pathol 2022. [PMID: 35260826 DOI: 10.1038/s41379-022-01056-0] [Reference Citation Analysis]
30 Dunbar KB, Souza RF. Beyond Dysplasia Grade: The Role of Biomarkers in Stratifying Risk. Gastrointest Endosc Clin N Am 2017;27:447-59. [PMID: 28577766 DOI: 10.1016/j.giec.2017.02.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
31 Saller J, Jiang K, Xiong Y, Yoder SJ, Neill K, Pimiento JM, Pena L, Corbett FS, Magliocco A, Coppola D. A microRNA Signature Identifies Patients at Risk of Barrett Esophagus Progression to Dysplasia and Cancer. Dig Dis Sci 2021. [PMID: 33713247 DOI: 10.1007/s10620-021-06863-0] [Reference Citation Analysis]
32 Stabenau KA, Samuels TL, Lam TK, Mathison AJ, Wells C, Altman KW, Battle MA, Johnston N. Pepsinogen/Proton Pump Co-Expression in Barrett's Esophageal Cells Induces Cancer-Associated Changes. Laryngoscope 2022. [PMID: 35315085 DOI: 10.1002/lary.30109] [Reference Citation Analysis]
33 Korbut E, Janmaat VT, Wierdak M, Hankus J, Wójcik D, Surmiak M, Magierowska K, Brzozowski T, Peppelenbosch MP, Magierowski M. Molecular Profile of Barrett's Esophagus and Gastroesophageal Reflux Disease in the Development of Translational Physiological and Pharmacological Studies. Int J Mol Sci 2020;21:E6436. [PMID: 32899384 DOI: 10.3390/ijms21176436] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
34 Vasanthan KS, Srinivasan V, Mathur V, Agarwal P, Negi N, Kumari S. 3D Bioprinting for esophageal tissue regeneration: A review. Journal of Materials Research. [DOI: 10.1557/s43578-021-00409-w] [Reference Citation Analysis]
35 Schoofs N, Bisschops R, Prenen H. Progression of Barrett's esophagus toward esophageal adenocarcinoma: an overview. Ann Gastroenterol. 2017;30:1-6. [PMID: 28042232 DOI: 10.20524/aog.2016.0091] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]